Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following downregulation of tumor progesterone receptor
- 1 February 1992
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 62 (2) , 107-114
- https://doi.org/10.1016/0304-3835(92)90180-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Designing a schedule of progestin administration in the control of endometrial carcinoma growth in the nude mouse modelAmerican Journal of Obstetrics and Gynecology, 1990
- Steroid receptors and human endometrial carcinoma: studies in a nude mouse modelCancer and Metastasis Reviews, 1987
- Monoclonal Antibodies to Human Progesterone Receptor: Characterization by Biochemical and Immunohistochemical Techniques*Endocrinology, 1987
- Human Endometrial Adenocarcinoma Transplanted into Nude Mice: Growth Regulation by EstradiolScience, 1983
- Cytoplasmic and Nuclear Estradiol and Progesterone Receptors in Human Endometrium*Journal of Clinical Endocrinology & Metabolism, 1978
- The regulation of the progesterone “receptor” in Guinea pig uterus: Dependence on estrogen and progesteroneSteroids, 1974
- Mechanisms Regulating the Concentration and the Conformation of Progesterone Receptor(s) in the UterusJournal of Biological Chemistry, 1973
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970